ReviewFrontiers in reproductive health2025
A sustainable public health framework for PCOS management in low- and middle-income countries: a narrative review.
Review in Frontiers in reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prevalence of polycystic ovary syndrome and determinants of knowledge among women in the eastern province Saudi Arabia.Frontiers in reproductive health · 2026Article
- Physical activity, sedentary behavior, and metabolic-reproductive health in women with PMOS (PCOS): a narrative review of mechanisms, clinical evidence, and individualized intervention strategies.Frontiers in endocrinology · 2026Review
- Global, regional, and national burden of infertility attributable to polycystic ovary syndrome, 1990-2021: results from the Global Burden of Disease Study 2021.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic Ovary Syndrome is an endocrine disorder that affects reproductive, metabolic, and mental health. In LMICs, PCOS management is hindered by late diagnosis, lack of awareness, and high treatment costs which leads to long-term complications. Objective: The aim of the review is to document the challenges in PCOS diagnosis and management in LMICs and provide public health solution to overcome these barriers in accordance with SDG goals. Methods: A narrative review synthesizing existing literature on PCOS epidemiology, barriers to diagnosis and treatment, and potential solutions relevant to LMICs. Results: Key challenges include lack of uniformity in diagnosis and treatment, lack of trained HR and equipment. High cost of care, stigma and fragmented health care. Outcomes/proposed solutions: Develop national PCOS guidelines, bring the management of PCOS under the reproductive health program, shift some of the tasks to primary health workers, like generating awareness and screening for symptoms. Invest in research to find public health solutions. Conclusion: Addressing PCOS in LMICs requires a multi-sectoral public health approach, including prevention, early detection, and affordable care. Strengthening healthcare systems through policy reforms and community-based interventions can improve outcomes for affected women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.